Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Matas

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Current Opinion in Organ Transplantation|March 25, 2009
Incentives for organ donation in the United States: feasible alternative or forthcoming apocalypse?Benjamin Hippen, Arthur Matas
Transplantation|April 14, 2010
Promotion of altruistic donation: a replyBenjamin Hippen, Arthur Matas
The Hastings Center Report|January 6, 2010
The point of control: Can a regulated organ market be moral?Benjamin Hippen, Arthur Matas
Journal of the American Society of Nephrology : JASN|April 7, 2025
Late Allograft Loss and Contemporary Cardiorenal Metabolic TherapiesAmanda J Vinson, Arthur Matas
JAMA|July 21, 2025
The End Kidney Deaths ActElaine Perlman, Frederike Ambagtsheer, Arthur Matas
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 25, 2012
Selection of controls in kidney donor outcome studies: an admirable effortScott Reule, Arthur Matas, Hassan N Ibrahim
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 17, 2002
Improved late graft survival and half-lives in pediatric kidney transplantation: a single center experienceAbhay Vats, Kristen Gillingham, Arthur Matas, et al.
Head & Neck|April 5, 2002
Squamous cell carcinoma of the head and neck in solid organ transplant recipientsDiego A Preciado, Arthur Matas, George L Adams
Clinical Transplantation|March 27, 2013
The impact of C4d and microvascular inflammation before we knew themPriya Verghese, Ty Dunn, Behzad Najafian, et al.
Transplantation|September 17, 2004
Human leukocyte antigen type as a risk factor for nonmelanomatous skin cancer in patients after renal transplantationAdam Bock, Robin L Bliss, Arthur Matas, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Current Opinion in Organ Transplantation|March 25, 2009
Incentives for organ donation in the United States: feasible alternative or forthcoming apocalypse?Benjamin Hippen, Arthur Matas
Transplantation|April 14, 2010
Promotion of altruistic donation: a replyBenjamin Hippen, Arthur Matas
The Hastings Center Report|January 6, 2010
The point of control: Can a regulated organ market be moral?Benjamin Hippen, Arthur Matas
Journal of the American Society of Nephrology : JASN|April 7, 2025
Late Allograft Loss and Contemporary Cardiorenal Metabolic TherapiesAmanda J Vinson, Arthur Matas
JAMA|July 21, 2025
The End Kidney Deaths ActElaine Perlman, Frederike Ambagtsheer, Arthur Matas
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 25, 2012
Selection of controls in kidney donor outcome studies: an admirable effortScott Reule, Arthur Matas, Hassan N Ibrahim
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 17, 2002
Improved late graft survival and half-lives in pediatric kidney transplantation: a single center experienceAbhay Vats, Kristen Gillingham, Arthur Matas, et al.
Head & Neck|April 5, 2002
Squamous cell carcinoma of the head and neck in solid organ transplant recipientsDiego A Preciado, Arthur Matas, George L Adams
Clinical Transplantation|March 27, 2013
The impact of C4d and microvascular inflammation before we knew themPriya Verghese, Ty Dunn, Behzad Najafian, et al.
Transplantation|September 17, 2004
Human leukocyte antigen type as a risk factor for nonmelanomatous skin cancer in patients after renal transplantationAdam Bock, Robin L Bliss, Arthur Matas, et al.
Pageof 6